Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects
Clinical trial NCT06280534 · UNKNOWN
Trial details
- NCT number
- NCT06280534
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-18
- Primary completion
- 2024-02-29
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.